Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.

Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...

Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral hepatitis, alcohol use, and obesity increase the likelihood of hepatocellular ...

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease. But researchers at McMaster University in collaboration with ...

Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal approaches.

Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without tumour progression in response to standard treatment according to a new study ...

Liver cancer stands among the most aggressive forms of the disease, often presenting no symptoms until it reaches advanced stages when treatment options become severely limited. This silent ...

Mental health conditions such as alcohol use disorder and PTSD could significantly increase risk for liver cancer among ...